immune checkpoint inhibitor

Events
pharmaphorum
Partner Content

STING & TLR Targeting Therapies Summit

This is the definitive drug development forum for research teams to investigate how to modulate the cGAS-STING and Toll-like receptor (7/8/9) pathways both as monotherapies and as

Events
Harnessing TIGIT Checkpoint Inhibitor Therapies as the Next Pillar of Frontline Cancer Treatments
Partner Content

TIGIT Therapies Digital Summit

The TIGIT checkpoint has gained much attention in recent years due to the number of roles it plays in several malignancies.